Status
Conditions
Treatments
About
The objective of this multicenter, prospective, open-label, controlled, randomized trial is to demonstrate the superiority of drug-coated balloon (DCB) treatment on non-flow limited vulnerable plaque as compared to guideline-directed medical therapy (GDMT) in improving clinical cardiovascular outcomes in patients with acute coronary syndrome.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
1,860 participants in 2 patient groups
Loading...
Central trial contact
Haibo Jia, PhD
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal